ferric reduction ability of serum (fras) assay Search Results


ferric reduction ability of serum (fras) assay  (BASF)
90
BASF ferric reduction ability of serum (fras) assay
<t>FRAS</t> testing ( A ) Cu NP, Cu NP ions, Cu NW and Cu NW ions ( B ) Ni NP, Ni NP ions, Ni NW and Ni NW ions ( C ) TiO 2 NP and TiO 2 NW. Error bars indicate one standard deviation from triplicate testing, and are smaller than the size of the symbol in most cases. Statistics were performed using either ANOVA-Dunnett’s T3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) or the 2-sided Dunnett’s test (‡ p ≤ 0.05, ‡‡‡ p ≤ 0.001).
Ferric Reduction Ability Of Serum (Fras) Assay, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ferric+reduction+ability+of+serum+(fras)+assay/ferric+reduction+ability+of+serum++fras++assay/pmc08746854-112-13-20
Average 90 stars, based on 1 article reviews
ferric reduction ability of serum (fras) assay - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


FRAS testing ( A ) Cu NP, Cu NP ions, Cu NW and Cu NW ions ( B ) Ni NP, Ni NP ions, Ni NW and Ni NW ions ( C ) TiO 2 NP and TiO 2 NW. Error bars indicate one standard deviation from triplicate testing, and are smaller than the size of the symbol in most cases. Statistics were performed using either ANOVA-Dunnett’s T3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) or the 2-sided Dunnett’s test (‡ p ≤ 0.05, ‡‡‡ p ≤ 0.001).

Journal: Nanomaterials

Article Title: Comparison of Metal-Based Nanoparticles and Nanowires: Solubility, Reactivity, Bioavailability and Cellular Toxicity

doi: 10.3390/nano12010147

Figure Lengend Snippet: FRAS testing ( A ) Cu NP, Cu NP ions, Cu NW and Cu NW ions ( B ) Ni NP, Ni NP ions, Ni NW and Ni NW ions ( C ) TiO 2 NP and TiO 2 NW. Error bars indicate one standard deviation from triplicate testing, and are smaller than the size of the symbol in most cases. Statistics were performed using either ANOVA-Dunnett’s T3 (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001) or the 2-sided Dunnett’s test (‡ p ≤ 0.05, ‡‡‡ p ≤ 0.001).

Article Snippet: The SOP, which described the multi-dose protocol of the Ferric Reduction Ability of Serum (FRAS) assay, published in 2017 by BASF [ ], was used for reactivity testing of samples under physiological conditions.

Techniques: Standard Deviation